research chemical raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-25 and is reviewed periodically as new material appears.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also marketed informally as Stenabolic |
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ |
| Molecular formula | C24H30ClN3O4S | Approximate molecular weight 492 g/mol |
| CAS Registry Number | 1379686-30-2 | Identifier for the parent compound |
| Regulatory status | Not approved for human use | Prohibited in sport by WADA |
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
The Rejuvant study (a human clinical trial) reported that the median and range of the biological age of females before treatment was 62.15 (range, 46.4 to 73) years and fell to 55.55 (range 33.4 to 63.7) years after an average of 7 months treatment. These values for men were 61.85 (range 41.9 to 79.7) years before and 53.3 (33 to 74.9) years after treatment. Overall, the combined group of males and females showed an average fall in biological age of 8 years compared to before treatment. The p-value for this difference was extraordinarily significant, i.e., 6.538x10-12, in showing that this treatment decreased the participants' biological ages. However, the study did not: a) include a control group (i.e., concurrent study of individuals taking a placebo instead of Rejuvant®); b) determine if the retinyl palmitate, vitamin A, and/or calcium given with α-ketoglutarate contributed to the changes in biological ages; and c) disclose which genes were tracked for the methylation of their CpG island. The study recommended that studies need to include control groups taking a placebo or the appropriate dosages of retinyl palmitate, vitamin A, and calcium. Also, TruMe Labs, who were the maker and marketer of the biological age assay used in this study, sponsored part of the study and contributed three of its employees as authors to the study.
1993/2924) Social Security (Contributions) Amendment (No. 7) Regulations 1993 (S.I. 1993/2925) Dundee Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2926) Falkirk and District Royal Infirmary National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2927) Hairmyres and Stonehouse Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2928) Law Hospital National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2929) Perth and Kinross Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2930) East and Midlothian National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2931) Royal Infirmary of Edinburgh National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2932) Western General Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2933) Dumfries and Galloway Acute and Maternity Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2934) Glasgow Community and Mental Health Services National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2935) Edinburgh Sick Children's National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2936) Fife Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2937) Edinburgh Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2938) Petroleum Revenue Tax (Nomination Scheme for Disposals and Appropriations) (Amendment) Regulations 1993 (S.I.
== Society and culture == Melarsoprol is produced by Sanofi and under an agreement with the WHO, it donates melarsoprol to countries where the disease is common. Melarsoprol was used to treat a patient with second-stage African trypanosomiasis on season 1 episode 7 "Fidelity" of the medical drama House MD.
As with animal findings, both TMPAA and NAM have been said to be inactive based on human tests. It has also been noted that metabolites like TMPA and TMPE are rapidly metabolized. As such, metabolites of mescaline like TMPA, TMPE, TMPAA, and NAM do not appear to be involved in the drug's psychedelic-related effects. 3,4,5-Trimethoxyamphetamine (TMA), the α-methyl analogue of mescaline and an MAO-resistant psychedelic, is only about twice as potent as mescaline as a psychedelic in humans despite having similar serotonin receptor affinity. This suggests that the deamination of mescaline has a relatively limited impact on its potency, compared to for example the 2C series of psychedelics. Another analogue of mescaline, the deuterated isotopologue Alpha-D (α,α-dideuteromescaline), has been reported to be roughly one-third more potent than mescaline as a psychedelic in humans, albeit based on limited testing. This is consistent with findings of about one-third of a dose of mescaline being metabolized via deamination.
Sources: en.wikipedia.org
Inkjet (dot on demand or continuous) systems are capable of printing high resolution (300 dpi or higher for dot on demand) images at press speed (up to 1000fpm). These solutions can be deployed either on-press or off-line. Laser marking can be employed to ablate a coating or to cause a color change in certain materials. The advantage of laser is fine detail and high speed for character printing, and no consumables. Not all substrates accept a laser mark, and certain colors (e.g. red) are not suitable for barcode reading. Thermal Transfer and Direct Thermal. For lower speed off-press applications, thermal transfer and direct thermal printers are ideal for printing variable data on labels. Software systems are available for managing traceability throughout the entire production, processing, marketing and distribution system. Some of these software systems combine multiple software modules allowing the producer to capture traceability information from all farming, processing and packing activities. Others, capture data in the field and packing operations to integrate with retail buying platforms and carry data all the way to the end consumer. Leveraging new advancements in mobile technology, food brands are now incorporating mobile messaging and QR codes on product labels. Consumers can text or scan the barcode with smartphones for immediate retrieval of product information. Consumers can also trace the origins of their purchased produce at websites.
=== Nora Braverman === Nora Braverman (Mia and Ella Allan), the youngest of Adam and Kristina's three children, was born in late 2011. Her father Adam was negotiating a huge business deal at the time of her birth and was unable to get phone signal coverage; as a result, his brother, Crosby, helped Adam's wife deliver the child.
All-cause mortality is higher above 64 mmol/mol (8.0 DCCT%) HbA1c as well as below 42 mmol/mol (6.0 DCCT %) in diabetic patients, and above 42 mmol/mol (6.0 DCCT %) as well as below 31 mmol/mol (5.0 DCCT %) in non-diabetic persons, indicating the risks of hyperglycemia and hypoglycemia, respectively. Similar risk results are seen for cardiovascular disease. The 2022 ADA guidelines reaffirmed the recommendation that HbA1c should be maintained below 7.0% for most patients. Higher target values are appropriate for children and adolescents, patients with extensive co-morbid illness and those with a history of severe hypoglycemia. More stringent targets (<6.0%) are preferred for pregnant patients if this can be achieved without significant hypoglycemia.
== Mass spectrometry == Generally this topic is discussed when covering mass spectrometry and occurs generally by the same mechanisms. To neutralize the positive charge on the ionization site a single two-electron transfer must be made. Neutralization of the positive charge at the ionization site is performed at the expense of the atom adjacent to the ionization site, transferring the positive charge to this atom as a result of the bond cleavage.
Pumpable ice flows like water, and because it is homogeneous, it cools fish faster than fresh water solid ice methods and eliminates freeze burns. It complies with HACCP and ISO food safety and public health standards, and uses less energy than conventional fresh water solid ice technologies.
Sources: en.wikipedia.org
=== Research === A major source of bubble instability is when a wide variety of sizes of bubbles are created, gases in smaller bubbles diffuses or disperses into larger bubbles. This is due to their differing Laplace pressures. As of 2023, technologies to control bubble size, distribution and movement were difficult to employ during production. "Advanced" research was underway, including by companies such as Nestlé. In 2013, scientists released the results of experimental research on the impact of phospholipids on aerating cocoa butter. The research found that although all phospholipids tested made cocoa butter foam more, the foam's stability varied by type of phospholipid. The final cocoa butter was also observed to be more stable when the process was undertaken at lower temperatures.
Since 1971, SI defined the "amount of substance" as a separate dimension of measurement. Until 2019, the mole was defined as the amount of substance that has as many constituent particles as there are atoms in 12 grams of carbon-12, with the dalton defined as +1/12 of the mass of a carbon-12 atom. Thus, during that period, the numerical value of the molar mass of a substance expressed in g/mol was exactly equal to the numerical value of the average mass of an entity (atom, molecule, formula unit) of the substance expressed in daltons. Since 2019, the mole has been redefined in the SI as the amount of any substance containing exactly 6.02214076×1023 entities, fixing the numerical value of the Avogadro constant NA when expressed in the unit mol−1, but because the dalton is still defined in terms of the experimentally determined mass of a carbon-12 atom, the numerical equivalence between the molar mass of a substance and the average mass of an entity of the substance is now only approximate, but equality may still be assumed with high accuracy—(the relative discrepancy is only of order 10–9, i.e. within a part per billion).
She has given a great deal of thought to how women are taught to act as they grow up and how that may impact their career decisions. In an interview in 2004, Osborn said, "In deciding whether to accept new challenges a remark by Diane Britten some years ago in The Times has proved very helpful: "When asked to do something women tend to say `Why me?' Men say `Why not me?' I have learned to say `Why not me?''' Summing up her advice to those in charge of sciences in universities and industry, she said in 2012, "Above all one has to get the argument across that it is wasteful, expensive and unfair to educate and train large numbers of woman scientists and then not use their talents in the job market or provide equal access to the top jobs."
Evocative/suppression testing refers to a class of tests performed where one substance is measured both before and after the administration of another substance to determine if the levels are stimulated ("evocative") or suppressed. They are most commonly performed in the evaluation of possible endocrine disorders. Certain tests are performed in the evaluation of multiple conditions, and not all listed substances may be measured in each test. Examples include:
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.
No. SR9009 has not been approved as a therapeutic drug in the United States, European Union, or other major markets. Human safety and efficacy data are very limited. Its presence in consumer products does not imply regulatory approval.
The World Anti-Doping Agency lists SR9009 as a prohibited substance because it can alter gene expression and metabolic pathways relevant to performance. The ban applies at all times, not only during competition. Detection relies on laboratory methods such as mass spectrometry.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.